SAN DIEGO, CA – June 14, 2018: CureMatch wins Metroconnect startup pitchfest. Global expansion to include Center for Oncology in Pediatrics (COP) in Mexico. A $35,000 grant will support foreign market expansion of CureMatch precision oncology technology to improve cancer treatment outcomes around the globe.
When it comes to cancer treatment in Mexico, just like in the United States, many cancer patients and their doctors still rely on traditional “one-size-fits-all” methods of care. CureMatch is looking to extend Precision Medicine technology to doctors and facilities responsible for any cancer treatment in Mexico.
SOTERIA Precision Medicine Advisory, Inc. and CureMatch, Inc. have entered into an agreement that will facilitate the delivery of Personalized Combination Therapy® options to the global cancer care community. As a premier concierge precision medicine advisory company, Soteria provides client guidance related to individualized tumor profiling services. In turn, CureMatch evaluates a patient’s sequencing data and prior drug history to rank the top mono-therapies, two-drug combinations, and three-drug combinations along with any specifically selected treatment options for the oncologists’ consideration.
CureMatch is proud to be one of the sponsors of this year’s 14th Moores Cancer Center Industry/Academia Translational Oncology Symposium which will be held on Thursday, February 22, 2018 (8am-6pm) at the Moores Cancer Center, located at 3855 Health Sciences Drive, La Jolla, CA 92093. Featuring Duane Roth Award Lecture Engineered T-Cells: The Sky’s the Limit Carl June, MD […]
Dubai, United Arab Emirates, September 19, 2016 – CureMatch, Inc., a San Diego-based digital health company, was accepted into the inaugural Dubai Future Accelerators program. CureMatch is transforming the standard of care in oncology. The CureMatch proprietary decision support system guides oncologists in the selection of drug combinations for improved cancer therapy. A team from […]
